Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REINSURANCE GROUP OF AMERICA, INCORPORATED

(RGA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Reinsurance of America Incorporated : 1Q21 Earnings Presentation

05/07/2021 | 11:48am EDT

The security of experience. The power of innovation.

1Q21 Earnings Presentation

Reinsurance Group of America, Incorporated

May 6, 2021

Safe Harbor

This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, among others, statements relating to projections of the future operations, strategies, earnings, revenues, income or loss, ratios, financial performance and growth potential of the Company. Forward-looking statements often contain words and phrases such as "intend," "expect," "project," "estimate," "predict," "anticipate," "should," "believe" and other similar expressions. Forward-looking statements are based on management's current expectations and beliefs concerning future developments and their potential effects on the Company. Forward-looking statements are not a guarantee of future performance and are subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results, performance, and achievements could differ materially from those set forth in, contemplated by or underlying the forward-looking statements.

The effects of the COVID-19 pandemic and the response thereto on economic conditions, the financial markets and insurance risks, and the resulting effects on the Company's financial results, liquidity, capital resources, financial metrics, investment portfolio and stock price, could cause actual results and events to differ materially from those expressed or implied by forward-looking statements. Further, the estimates, projections, illustrative scenarios or frameworks used to plan for potential effects of the pandemic are dependent on numerous underlying assumptions and estimates that may not materialize. Additionally, numerous other important factors (whether related to, resulting from or exacerbated by the COVID-19 pandemic or otherwise) could also cause results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation: (1) adverse changes in mortality, morbidity, lapsation or claims experience, (2) inadequate risk analysis and underwriting,

  1. adverse capital and credit market conditions and their impact on the Company's liquidity, access to capital and cost of capital, (4) changes in the Company's financial strength and credit ratings and the effect of such changes on the Company's future results of operations and financial condition, (5) the availability and cost of collateral necessary for regulatory reserves and capital, (6) requirements to post collateral or make payments due to declines in market value of assets subject to the Company's collateral arrangements, (7) action by regulators who have authority over the Company's reinsurance operations in the jurisdictions in which it operates, (8) the effect of the Company parent's status as an insurance holding company and regulatory restrictions on its ability to pay principal of and interest on its debt obligations, (9) general economic conditions or a prolonged economic downturn affecting the demand for insurance and reinsurance in the Company's current and planned markets, (10) the impairment of other financial institutions and its effect on the Company's business, (11) fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets, (12) market or economic conditions that adversely affect the value of the Company's investment securities or result in the impairment of all or a portion of the value of certain of the Company's investment securities, that in turn could affect regulatory capital, (13) market or economic conditions that adversely affect the Company's ability to make timely sales of investment securities, (14) risks inherent in the Company's risk management and investment strategy, including changes in investment portfolio yields due to interest rate or credit quality changes, (15) the fact that the determination of allowances and impairments taken on the Company's investments is highly subjective, (16) the stability of and actions by governments and economies in the markets in which the Company operates, including ongoing uncertainties regarding the amount of U.S. sovereign debt and the credit ratings thereof, (17) the Company's dependence on third parties, including those insurance companies and reinsurers to which the Company cedes some reinsurance, third-party investment managers and others, (18) financial performance of the Company's clients, (19) the threat of natural disasters, catastrophes, terrorist attacks, epidemics or pandemics anywhere in the world where the Company or its clients do business, (20) competitive factors and competitors' responses to the Company's initiatives, (21) development and introduction of new products and distribution opportunities,
  1. execution of the Company's entry into new markets, (23) integration of acquired blocks of business and entities, (24) interruption or failure of the Company's telecommunication, information technology or other operational systems, or the Company's failure to maintain adequate security to protect the confidentiality or privacy of personal or sensitive data and intellectual property stored on such systems,
  1. adverse litigation or arbitration results, (26) the adequacy of reserves, resources and accurate information relating to settlements, awards and terminated and discontinued lines of business, (27) changes in laws, regulations, and accounting standards applicable to the Company or its business, (28) the effects of the Tax Cuts and Jobs Act of 2017 may be different than expected and (29) other risks and uncertainties described in this document and in the Company's other filings with the Securities and Exchange Commission ("SEC").

Forward-looking statements should be evaluated together with the many risks and uncertainties that affect the Company's business, including those mentioned in this document and described in the periodic reports the Company files with the SEC. These forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligation to update these forward-looking statements, even though the Company's situation may change in the future. For a discussion of these risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, you are advised to see Item 1A - "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, as may be supplemented by Item 1A - "Risk Factors" in the Company's subsequent Quarterly Reports on Form 10-Q.

2

Use of Non-GAAP Financial Measures

RGA uses a non-GAAP financial measure called adjusted operating income as a basis for analyzing financial results. This measure also serves as a basis for establishing target levels and awards under RGA's management incentive programs. Management believes that adjusted operating income, on a pre-tax and after-tax basis, better measures the ongoing profitability and underlying trends of the Company's continuing operations, primarily because that measure excludes substantially all of the effects of net investment-related gains and losses, as well as changes in the fair value of certain embedded derivatives and related deferred acquisition costs. These items can be volatile, primarily due to the credit market and interest rate environment, and are not necessarily indicative of the performance of the Company's underlying businesses. Additionally, adjusted operating income excludes any net gain or loss from discontinued operations, the cumulative effect of any accounting changes, tax reform, and other items that management believes are not indicative of the Company's ongoing operations. The definition of adjusted operating income can vary by company and this measure is not considered a substitute for GAAP net income.

RGA uses a second non-GAAP financial measure called adjusted operating revenues as a basis for measuring performance. This measure excludes the effects of net realized capital gains and losses, and changes in the fair value of certain embedded derivatives. The definition of adjusted operating revenues can vary by company and this measure is not considered a substitute for GAAP revenues.

Additionally, the Company evaluates its stockholders' equity position excluding the impact of accumulated other comprehensive income ("AOCI"), a non-GAAP financial measure. The Company believes it is important to evaluate its stockholders' equity position excluding the effect of AOCI because the net unrealized gains or losses included in AOCI primarily relate to changes in interest rates, changes in credit spreads on investment securities, and foreign currency fluctuations that are not permanent and can fluctuate significantly from period to period.

Book value per share before the impact of AOCI is a non-GAAP financial measure that management believes is important in evaluating the balance sheet in order to exclude the effects of unrealized amounts primarily associated with mark-to-market adjustments on investments and foreign currency translation.

Adjusted operating earnings per diluted share is a non-GAAP financial measure calculated as adjusted operating income divided by weighted average diluted shares outstanding. Adjusted operating return on equity is a non-GAAP financial measure calculated as adjusted operating income divided by average stockholders' equity excluding AOCI. Similar to adjusted operating income, management believes these non-GAAP financial measures better reflect the ongoing profitability and underlying trends of the Company's continuing operations. They also serve as a basis for establishing target levels and awards under RGA's management incentive programs.

Reconciliations of non-GAAP financial measures to the nearest GAAP financial measures are provided in the Appendix at the end of this presentation.

3

Key Messages

RGA's Global Platform Continues to Demonstrate Resilience

  • Results were solid as adjusted operating loss of $1.241 per diluted share included $5.312 per diluted share of COVID-19 impacts
  • Premiums increased 3%; deployed $100 million of capital into transactions
  • Variable investment income (VII) was strong due to limited partnership (LP) investment performance3
  • Excess capital of $1.2 billion with ample liquidity
  • RGA ranked #1 in business capabilities in NMG4 survey for 10th year in a row

Significant COVID-19 Impact Was Manageable

  • Q1 COVID-19 claim costs
    • $340 million of estimated COVID-19 U.S. individual mortality claim costs
    • $145 million of estimated COVID-19 claim costs in all other operations
  • Expect vaccination roll out to lower our mortality claim costs for the remainder of 2021

1

Please refer to "Reconciliations of Non-GAAP Measures" in the Appendix.

4

2

COVID-19-related impact estimates include mortality and morbidity claims with offsetting impacts from longevity.

  1. Variable investment income included an accounting correction on LP investments from prior periods.
  2. NMG Consulting Global Life & Health Reinsurance Study 2020.

Estimated COVID-19 Earnings Impacts

  • COVID-19impacts consistent with higher general population reported deaths
  • Although overall COVID-19 claim costs were higher than previous quarters, they continue to be within our expected range
  • Longevity experience impact was lower than expected due to longer reporting lags

Estimated Pre-taxCOVID-19 Impacts1

1Q21

20202

Mortality and Morbidity

$(485)

$(720)

Longevity

$11

$33

1

$ in millions.

5

2 Full year amounts include refinements to previous estimates based upon updated reporting.

Disclaimer

Reinsurance Group of America Inc. published this content on 06 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 May 2021 15:47:02 UTC.


© Publicnow 2021
All news about REINSURANCE GROUP OF AMERICA, INCORPORATED
06/08REINSURANCE OF AMERICA INCORPORATED  : RGA Announces Annuity Reinsurance Transac..
PU
06/03REINSURANCE OF AMERICA INCORPORATED  : RGA Ranked #207 on the 2021 Fortune 500 L..
PU
06/02SECTOR UPDATE : Financial Stocks Climb Pre-Bell Wednesday
MT
06/01REINSURANCE OF AMERICA INCORPORATED  : Group of America Signs Agreement With Dai..
MT
06/01REINSURANCE OF AMERICA INCORPORATED  : Group of America Reinsures 200 Billion JP..
BU
05/24China Reinsurance's January-April Premium Income Tops $2 Billion
MT
05/20REINSURANCE GROUP OF AMERICA INC  : Change in Directors or Principal Officers, S..
AQ
05/20INSIDER TRENDS : Reinsurance Group of America Insider Receives Stock Award, Tren..
MT
05/20INSIDER TRENDS : Reinsurance Group of America Insider Gets Stock Award, Extends ..
MT
05/20INSIDER TRENDS : Reinsurance Group of America Insider Gets Stock Award, Buy Tren..
MT
More news
Financials (USD)
Sales 2021 15 296 M - -
Net income 2021 726 M - -
Net Debt 2021 4 015 M - -
P/E ratio 2021 12,5x
Yield 2021 2,33%
Capitalization 8 444 M 8 444 M -
EV / Sales 2021 0,81x
EV / Sales 2022 0,78x
Nbr of Employees 3 600
Free-Float 79,4%
Chart REINSURANCE GROUP OF AMERICA, INCORPORATED
Duration : Period :
Reinsurance Group of America, Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REINSURANCE GROUP OF AMERICA, INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 130,44 $
Last Close Price 123,20 $
Spread / Highest target 21,8%
Spread / Average Target 5,88%
Spread / Lowest Target -38,3%
EPS Revisions
Managers and Directors
NameTitle
Anna Manning President, Chief Executive Officer & Director
Todd C. Larson Chief Financial Officer & Senior Executive VP
J. Cliff Eason Chairman
Suzy Scanlon Chief Information Officer & Executive VP
Alain P. Néemeh Chief Operating Officer & Senior Executive VP
Sector and Competitors